Antibiotics | Aminoglycosides | Quinolones | β-lactams | |||||||||
GEN n (%) | TOB n (%) | NET n (%) | AK n (%) | NA n (%) | OFX n (%) | CIP n (%) | LEV n (%) | FOX n (%) | CTX n (%) | CAZ n (%) | TZP n (%) | |
ESBL-PE (n = 96) | 72 (75) | 83 (86.5) | 72 (75) | 17 (17.7) | 88 (91.7) | 87 (90.6) | 84 (87.5) | 76 (79.2) | - | - | - | - |
IMP-R (n = 14) | 3 (21.4) | 4 (28.6) | 4 (28.6) | 1 (7.1) | 6 (42.9) | 6 (42.9) | 6 (42.9) | 5 (35.7) | 5 (35.7) | 5 (35.7) | 5 (35.7) | 6 (42.9) |
ETP-R (n = 13) | 3 (23.1) | 4 (30.8) | 4 (30.8) | 1 (7.7) | 6 (46.2) | 6 (46.2) | 6 (46.2) | 5 (38.5) | 5 (38.5) | 5 (38.5) | 5 (38.5) | 6 (46.2) |
MRSA (n = 6) | 3 (50) | 3 (50) | - | 3 (50) | - | 4 (66.7) | - | - | - | - | - | - |